NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
12.41
+0.03 (0.24%)
Jan 29, 2026, 10:38 AM EST - Market open

NeoGenomics Revenue

NeoGenomics had revenue of $187.80M in the quarter ending September 30, 2025, with 11.90% growth. This brings the company's revenue in the last twelve months to $709.16M, up 10.10% year-over-year. In the year 2024, NeoGenomics had annual revenue of $660.57M with 11.65% growth.

Revenue (ttm)
$709.16M
Revenue Growth
+10.10%
P/S Ratio
2.23
Revenue / Employee
$322,346
Employees
2,200
Market Cap
1.61B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024660.57M68.92M11.65%
Dec 31, 2023591.64M81.92M16.07%
Dec 31, 2022509.73M25.40M5.24%
Dec 31, 2021484.33M39.88M8.97%
Dec 31, 2020444.45M35.62M8.71%
Dec 31, 2019408.83M132.09M47.73%
Dec 31, 2018276.74M36.49M15.19%
Dec 31, 2017240.25M8.44M3.64%
Dec 31, 2016231.81M132.01M132.27%
Dec 31, 201599.80M12.73M14.62%
Dec 31, 201487.07M20.60M31.00%
Dec 31, 201366.47M6.60M11.02%
Dec 31, 201259.87M16.38M37.68%
Dec 31, 201143.48M9.11M26.51%
Dec 31, 201034.37M4.90M16.63%
Dec 31, 200929.47M9.45M47.23%
Dec 31, 200820.02M8.51M73.97%
Dec 31, 200711.50M5.03M77.65%
Dec 31, 20066.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
OPKO Health642.07M
Veracyte495.14M
GeneDx Holdings402.19M
Twist Bioscience376.57M
CareDx358.00M
Castle Biosciences343.53M
Fulgent Genetics315.55M
Revenue Rankings